This laser is supposed to rejuvenate vaginal tissue. But scientists say it's no better than placebo
Vaginal laser therapy treatments claim to reduce negative vaginal symptoms of menopause – experienced by about half of all women – by up to 100 per
Stay updated with breaking news from Clinical Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vaginal laser therapy treatments claim to reduce negative vaginal symptoms of menopause – experienced by about half of all women – by up to 100 per
Share Manila: The Asian Development Bank (ADB) has joined with leading public health experts, vaccine regulators, and policy makers to form an advisory group to provide its developing member countries (DMCs) with expert technical and scientific advice on the quality, safety, and effectiveness of vaccines for the coronavirus disease (COVID-19) pandemic. The Regional Vaccine Advisory Group held its first meeting today and will help ADB and its DMCs better understand the regulatory oversight, risk management strategies, and pharmacovigilance needed to safely introduce and monitor vaccine rollou...
Researchers have evaluated 3D printed sample collection swabs made in-house and found them to be a reliable alternative to commercial swabs.
RepliCel Launches Preparations for Second Skin Rejuvenation and Tendon Regeneration Clinical Studies ACCESSWIRE 19 May 2021, 20:05 GMT+10 Clinical Research Organization, Accerise Inc., Has Been Retained To Work With RepliCel and Its Other Service Providers To Prepare Study Documentation, Plans, and Approvals for Clinical Evaluation by Multiple Clinical Sites in Japan VANCOUVER, BC / ACCESSWIRE / May 19, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ('RepliCel' or the 'Company'), a company developing next-generation technologies in aesthetics and orthopedics, is please...
To embed, copy and paste the code into your website or blog: MDR”), which will govern medical devices software (“ MDSW”) in the EU, we turn to the transition periods certain MDSW can benefit from before being required to fully comply with the MDR. Transitional periods are provided in Article 120 MDR. In part due to the COVID-19 pandemic, the original text of Article 120 MDR has been corrected by two corrigenda (I, II) and another Regulation to avoid additional burdens to stakeholders and impasses in the supply of medical devices. The changes introduced by these amendments are twofold: O...